Acambis Boosted In Battle For Smallpox Vaccine Market

Law360, New York (July 18, 2006, 12:00 AM EDT) -- Vaccine producer Acambis got a boost today in its battle with Bavarian Nordic A/S to become the supplier of smallpox vaccines to the U.S. government, with International Trade Commission transcripts indicating that the patents asserted by Bavarian Nordic are invalid.

In ITC cases brought under section 337 of the Tariff Act of 1930—like the Acambis/Bavarian Nordic matter—ITC staff attorneys argue on behalf of the public interest.

The opening statement of ITC lawyer Erin D.E. Joffre paints a bleak picture for complainant Bavarian Nordic and its prospects...
To view the full article, register now.